Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2002-03-21
2011-10-25
Kim, Young J (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S023100
Reexamination Certificate
active
08043807
ABSTRACT:
Methods and kits for (i) determining a risk of a subject to develop cancer; (ii) evaluating an effectiveness and dosage of cancer therapy administered to a cancer patient; and (iii) determining a presence of correlation or non-correlation between an activity of at least one DNA repair enzyme and at least one cancer, are disclosed.
REFERENCES:
patent: 5482833 (1996-01-01), Pero et al.
patent: 5482837 (1996-01-01), Albertini
patent: 2001/0031739 (2001-10-01), Dare
patent: 2003/0003454 (2003-01-01), Livneh et al.
patent: 62-224300 (1987-10-01), None
patent: WO 98/01838 (1998-01-01), None
patent: WO 99/04626 (1999-02-01), None
patent: WO 02/077280 (2002-10-01), None
Menegazzi et al. (1999) Correlation of Poly(ADP-ribose)polymerase and p53 expression levels in high-grade lymphomas. Molecular Carcinogenesis. 25:256-261.
Bouchard et al. PARP-1, a determinant of cell survival in response to DNA damage. Experimental Hematology (2003) 31: 446-454.
Chalmers, A.J. Poly(ADP-ribose) polymerase-1 and ionizing radiation: sensor, signaller and therapeutic target. Clinical Oncology (2004) 16: 29-39.
Loft et al. Cancer risk and oxidative DNA damage in man. Journal of Molecular Medicine (1996) 74: 297-312.
Suzuki et al. Changes in the urinary excretion level of 8-hydroxyguanine by exposure to reactive oxygen-generating substrates. Free Radical Biology & Medicine (1995) 18(3): 431-436.
Shinmura et al. Expression of the OGG1-type 1a (nuclear form) protein in cancerous and non-cancerous human cells. International Journal of Oncology (2000) 16: 701-707.
Wei et al. Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer. Cancer Epidemiology, Biomarkers, and Prevention (1998) 7: 309-314.
Silber et al. Lack of the DNA repair protein O6-methylguanine-DNA methyltransferase in histologically normal brain adjacent to primary brain tumors. Proceedings of the National Academy of Sciences, USA (1996) 93: 6941-6946.
Silber et al. Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain. Cancer Research (1993) 53: 3416-3420.
Gu et al. Human MutY homolog, a DNA glycosylase involved in base excision repair, physically and functionally interacts with mismatch repair proteins human MutS homolog 2/Human MutS homolog 6. The Journal of Biological Chemistry (2002) 277(13): 11135-11142.
Wei et al. Reduced expression of mismatch repair genes measured by multiplex reverse transcripion-polymerase chain reaction in human gliomas. Cancer Research (1997) 57: 1673-1677.
Lu et al. A mammalian DNA repair enzyme that excises oxidatively damaged guanines maps to a locus frequently lost in lung cancer. Current Biology (1997) 7: 397-407.
Audebert et al. Effect of single mutations in the OGG1 gene found in human tumors on the substrate specificity of the Ogg1 protein. Nucleic Acids Research (2000) 28(14): 2672-2678.
Wiencke et al. Correlation of DNA Adducts in Blood Mononuclear Cells with Tobacco Carcinogen-induced Damage in Human Lung. Cancer Research (1995) 55: 4910-4914.
Radak et al. Lung cancer in smoking patients inversely alters the activity of hOGG1 and hNTH1. Cancer Letters (2005) 219: 191-195.
Blons et al. Frequent Allelic Loss at Chromosome 3p Distinct from Genetic Alterations of the 8-Oxoguanine DNA Glycosylase 1 Gene in Head and Neck Cancer. Molecular Carcinogenesis (1999) 26: 254-260.
Park et al. Genetic changes of hOGG1 and the activity of oh8Gua glycosylase in colon cancer. European Journal of Cancer (2001) 37: 340-346.
Cheng et al. Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiology, Biomarkers & Prevention (1998) 7: 465-468.
Collins et al. Repair of oxidative DNA damage: assessing its contribution to cancer prevention. Mutagenesis (2002) 17(6): 489-493.
Wei et al. The role of DNA repair capacity in susceptibility to lung cancer: A review. Cancer and Metastasis Reviews (1997) 16: 295-307.
Koybasi et al. Defects in Cell Growth Regulation by C18:0-Ceramide and Longevity Assurance Gene 1 in Human Head and Neck Squamous Cell Carcinomas. The Journal of Biological Chemistry (2004) 279(43): 44311-44319.
Janssen et al. DNA repair activity of 8-oxoguanine DNA glycosylase 1 (OGG1) in human lymphocytes is not dependent on genetic polymorphism Ser326/Cys326. Mutation Research (2001) 486: 207-216.
Collins et al. Inter-individual differences in repair of DNA base oxidation, measured in vitro with the comet assay. Mutagenesis (2001) 16(4): 297-301.
Rajaee-Behbahani et al. Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer. International Journal of Cancer (2001) 95: 86-91.
Wei et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. Journal of the National Cancer Institute (2000) 92(21): 1764-1772.
Sagher et al. “Low O6-Alkylguanine DNA Alkyltranferase Activity in the Peripheral Blood Lymphocytes of Patients with Therapy-Related Acute Nonlymphocytic Leukemia”, Cancer Research 48: 3084-3089, 1988.
Sagher et al. “Heterogeneity of O6-Alkylguanine-DNA Alkyltransferase Activity in Peripheral Blood Lymphocytes: Relationship between this Activity in Lymphocytes and in Lymphoblastoid Lines from Normal Controls and from Patients with Hodgkin's Disease or Non-Hodgkin's Lymphoma”, Cancer Reseaerch, 49: 5339-5344, 1989.
Shinmura et al. “Infrequent Mutation of the hOGG1 Gene, that is Involved in the Excision of 8-Hydroxyguanine in Damaged DNA, in Human Gastric Cancer”, Jpn. J. Cancer Research, 89: 825-828, 1998.
Srivastava et al. “Germ-Line Transmission of a Mutated p53 Gene in a Cancer-Prone Family with Li-Fraumeny Syndome”, Natur, 348: 747-749, 1990.
Strauss “Translesion DNA Synthesis: Polymerase Response to Altered Nucleotides”, Cancer Surveys, 4(3): 494-516,1985.
Vandenbroucke et al. “Increased Risk of Venous Thrombosis in Oral-Contraceptive Users who are Carriers of Factor V Leiden Mutation”, The Lancet, 344: 1453-1457,1994.
Vogelstein et al. “The Multistep Nature of Cancer”, TIG,9(4), 1993.
Singhal et al. “DNA Polymerase β Conducts the Gap-Filling Step in Uracil-Initiated Base Excision Repair in a Bovine Testis Nuclear Extract”, The Journal of Biological Chemistry, 270(2): 949-957, 1995.
Weeda et al. “Genes Controlling Nucleotide Excision Repair in Eukaryotic Cells”, Bio Essays, 15(4): 249-258, 1993.
Wei et al. “Reduced DNA Repair Capacity in Lung Cancer Patients”, Cancer Research, 56:4103-4107, 1996.
Wei et al. “DNA Repair and Aging in Basal Cell Carcinoma: A Molecular Epidemiology Study”, PNAS,90: 1614-1618, 1993.
Wei et al. “DNA Repair and Susceptibility to Basal Cell Carcinoma: A Case-Control Study”, American Journal of Epidemiology, 140(7): 598-607,1994.
Weinberg “Oncogenes, Antioncogenes, and the Molecular Base of Multstep Carcinogenesis”,Cancer Research, 49:3713-3721, 1989.
Wikman et al. “hOGG1 Polymorphism and Loss of Hetrozygosity (LOH): Significance for Lung Cancer Suspectibility in a Caucasian Population”, In. Journal of Cancer, 88: 932-937, 2000.
Wood et al. “Mechnistic Studies of ionizing Radiation and Oxidative Mutagenesis: Genetic Effects of a Single 8-Hydroxyguanine (7-Hydro-8-Oxoguanine) Residue Inserted at a Unique Site in a Viral Genome”, Biochemistry, 29: 7024-7032, 1990.
Kang et al. “Intracellular Localization of 8-Oxo-dGTPase inHuman Cells, with Special Reference to the Role of the Enzyme in mitochondria”, The Journal of Biological Chemistry, 270(24): 14659-14665, 1995.
Krokan et al. “Base Excision Repair of DNA in Mammalian Cells”, FEBS Letters, 476: 73-77, 200.
Ladner et al. “The Human dUTPase Gene Encodes Both Nuclear and Mitochondrial Isoforms”, The Journal of Biological Chemistry, 272(30): 19072-19080, 1997.
Mo et al. “Hydrolytic Elimination of a Mutagenic Nucleotide, 8-OxodGTP, by Human 18-Kilodalton Protein: Sanitization of Nucleotide Po
Blumenstein Sara
Livneh Zvi
Paz-Elizur Tamar
Bertagna Angela
Kim Young J
Yeda Research and Development Co. Ltd.
LandOfFree
Methods and kits for determining a risk to develop cancer,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and kits for determining a risk to develop cancer,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and kits for determining a risk to develop cancer,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4282875